Among potential vaccines on clinical trials for the SARS-CoV-2 virus globally, the Ox1CoV-19 VIDA-Trials in Johannesburg is the sole candidate in Africa – a collaboration between Oxford University and University of Witswatersrand. This is worrisome despite capacities to conduct clinical trials in other countries including Senegal, Egypt and Algeria. Determined to increase this number, […]